• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
History of vaccination.疫苗接种史。
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7. doi: 10.1073/pnas.1400472111. Epub 2014 Aug 18.
2
Vaccines: the fourth century.疫苗:公元4世纪。
Clin Vaccine Immunol. 2009 Dec;16(12):1709-19. doi: 10.1128/CVI.00290-09. Epub 2009 Sep 30.
3
Evolution, benefits, and shortcomings of vaccine management.疫苗管理的演变、益处与缺点。
J Manag Care Pharm. 2007 Sep;13(7 Suppl B):S2-6. doi: 10.18553/jmcp.2007.13.s7-b.2a.
4
[On three revolutions of vaccine].论疫苗的三次变革
Zhonghua Yi Shi Za Zhi. 2006 Apr;36(2):104-8.
5
The development of vaccines: how the past led to the future.疫苗的发展:过去如何引领未来。
Nat Rev Microbiol. 2011 Oct 3;9(12):889-93. doi: 10.1038/nrmicro2668.
6
Live attenuated vaccines: Historical successes and current challenges.减毒活疫苗:历史上的成功与当前的挑战。
Virology. 2015 May;479-480:379-92. doi: 10.1016/j.virol.2015.03.032. Epub 2015 Apr 8.
7
Influenza vaccines: from whole virus preparations to recombinant protein technology.流感疫苗:从全病毒制剂到重组蛋白技术。
Expert Rev Vaccines. 2014 Jan;13(1):31-42. doi: 10.1586/14760584.2014.852476.
8
From brain passage to cell adaptation: the road of human rabies vaccine development.从脑部途径到细胞适应:人类狂犬病疫苗的发展之路。
Expert Rev Vaccines. 2011 Nov;10(11):1597-608. doi: 10.1586/erv.11.140.
9
A brief history of vaccines: smallpox to the present.疫苗简史:从天花到现代
S D Med. 2013;Spec no:33-7.
10
[Jenner and Pirjo].[詹纳和皮尔乔]
Duodecim. 1996;112(9):787-8.

引用本文的文献

1
A platform approach as a plausible option for nonclinical safety assessment of adjuvanted vaccines.作为佐剂疫苗非临床安全性评估的一种可行选择的平台方法。
NPJ Vaccines. 2025 Aug 13;10(1):192. doi: 10.1038/s41541-025-01245-3.
2
Global research hotspots and trends of the vaccines: Based on ESI hot papers.疫苗的全球研究热点与趋势:基于ESI热点论文
Hum Vaccin Immunother. 2025 Dec;21(1):2546195. doi: 10.1080/21645515.2025.2546195. Epub 2025 Aug 13.
3
Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives.用于疫苗开发的生物工程外膜囊泡:策略、进展与展望
Vaccines (Basel). 2025 Jul 20;13(7):767. doi: 10.3390/vaccines13070767.
4
The Application of Single-Cell Technologies for Vaccine Development Against Viral Infections.单细胞技术在抗病毒感染疫苗研发中的应用
Vaccines (Basel). 2025 Jun 26;13(7):687. doi: 10.3390/vaccines13070687.
5
Assessment of Oral Poliovirus Vaccine Viability and Titer at Delivery Points in Kinshasa, the Democratic Republic of the Congo: Implications for Cold Chain Management.刚果民主共和国金沙萨各配送点口服脊髓灰质炎疫苗活力和效价评估:对冷链管理的启示
Vaccines (Basel). 2025 Jun 25;13(7):680. doi: 10.3390/vaccines13070680.
6
Why the Jenner/Pasteur paradigm is insufficient for controlling vector-borne diseases and the role of microbiota-mediated interactions.为什么詹纳/巴斯德范式不足以控制媒介传播疾病以及微生物群介导的相互作用的作用。
Curr Res Parasitol Vector Borne Dis. 2025 Jul 8;8:100291. doi: 10.1016/j.crpvbd.2025.100291. eCollection 2025.
7
Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity.下一代疫苗平台:整合合成生物学、纳米技术和系统免疫学以提高免疫原性
Vaccines (Basel). 2025 May 30;13(6):588. doi: 10.3390/vaccines13060588.
8
Exploring Vaccine Hesitancy in the Philippines: A Content Analysis of Comments on National TV Channel YouTube Videos.探究菲律宾的疫苗犹豫现象:对国家电视频道YouTube视频评论的内容分析
Int J Environ Res Public Health. 2025 May 22;22(6):819. doi: 10.3390/ijerph22060819.
9
Value of Vaccinations: A Fundamental Public Health Priority to Be Fully Evaluated.疫苗接种的价值:一项有待全面评估的基本公共卫生优先事项。
Vaccines (Basel). 2025 Apr 29;13(5):479. doi: 10.3390/vaccines13050479.
10
Nanotechnology-based strategies for vaccine development: accelerating innovation and delivery.基于纳米技术的疫苗开发策略:加速创新与交付
Biomater Transl. 2025 Mar 25;6(1):55-72. doi: 10.12336/biomatertransl.2025.01.005. eCollection 2025.

本文引用的文献

1
Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.合成DNA疫苗:通过电穿孔和共递送基因佐剂提高疫苗效力。
Front Immunol. 2013 Nov 4;4:354. doi: 10.3389/fimmu.2013.00354.
2
Influenza vaccines: from whole virus preparations to recombinant protein technology.流感疫苗:从全病毒制剂到重组蛋白技术。
Expert Rev Vaccines. 2014 Jan;13(1):31-42. doi: 10.1586/14760584.2014.852476.
3
Crystal structure of a soluble cleaved HIV-1 envelope trimer.可溶性 HIV-1 包膜三聚体的晶体结构
Science. 2013 Dec 20;342(6165):1477-83. doi: 10.1126/science.1245625. Epub 2013 Oct 31.
4
A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines.一种新型、颠覆性的疫苗技术:自佐剂 RNActive(®)疫苗。
Hum Vaccin Immunother. 2013 Oct;9(10):2263-76. doi: 10.4161/hv.25181. Epub 2013 Jun 4.
5
WHO working group on the quality, safety and efficacy of japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21-23 February 2012.世界卫生组织人用乙型脑炎减毒活疫苗质量、安全性及效力工作组,泰国曼谷,2012年2月21 - 23日
Biologicals. 2013 Nov;41(6):450-7. doi: 10.1016/j.biologicals.2013.06.001. Epub 2013 Jul 25.
6
Systems biological approaches to measure and understand vaccine immunity in humans.系统生物学方法在人类疫苗免疫中的测量和理解。
Semin Immunol. 2013 Oct 31;25(3):209-18. doi: 10.1016/j.smim.2013.05.003. Epub 2013 Jun 21.
7
Progress on the research and development of inactivated EV71 whole-virus vaccines.肠道病毒 71 型灭活全病毒疫苗的研究与开发进展。
Hum Vaccin Immunother. 2013 Aug;9(8):1701-5. doi: 10.4161/hv.24949. Epub 2013 Jun 6.
8
Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.与使用减毒活疫苗脊灰病毒株相关的风险,以及控制和消灭麻痹性脊髓灰质炎的策略。
Expert Rev Vaccines. 2012 May;11(5):609-28. doi: 10.1586/erv.12.28.
9
Nomenclature for immune correlates of protection after vaccination.疫苗接种后免疫保护相关因素的命名。
Clin Infect Dis. 2012 Jun;54(11):1615-7. doi: 10.1093/cid/cis238. Epub 2012 Mar 20.
10
The development of vaccines: how the past led to the future.疫苗的发展:过去如何引领未来。
Nat Rev Microbiol. 2011 Oct 3;9(12):889-93. doi: 10.1038/nrmicro2668.

疫苗接种史。

History of vaccination.

作者信息

Plotkin Stanley

机构信息

Department of Pediatrics, University of Pennsylvania, Philadelphia, PA 19104

出版信息

Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7. doi: 10.1073/pnas.1400472111. Epub 2014 Aug 18.

DOI:10.1073/pnas.1400472111
PMID:25136134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4151719/
Abstract

Vaccines have a history that started late in the 18th century. From the late 19th century, vaccines could be developed in the laboratory. However, in the 20th century, it became possible to develop vaccines based on immunologic markers. In the 21st century, molecular biology permits vaccine development that was not possible before.

摘要

疫苗有着始于18世纪晚期的历史。从19世纪晚期开始,疫苗能够在实验室中研发。然而,在20世纪,基于免疫标记研发疫苗成为可能。在21世纪,分子生物学使此前不可能的疫苗研发成为现实。